| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.05 | 0.8 |